ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Biotechnol Biomater,

CRISPR Technology in Biotechnology: Editing the Future of Healthcare

Raiane Santos Leite*
Environmental Biotechnology Laboratory, LABAM, Federal University of Sergipe, Brazil
*Corresponding Author : Raiane Santos Leite, Environmental Biotechnology Laboratory, LABAM, Federal University of Sergipe, Brazil, Email: raianesantos78leite@gmail.com

Received Date: Jul 02, 2024 / Published Date: Jul 30, 2024

Abstract

CRISPR technology has emerged as a revolutionary tool in biotechnology, offering precise genome editing capabilities that are transforming healthcare and biomedical research. This article explores the principles of CRISPRCas systems, their applications in treating genetic disorders, cancer therapy, infectious disease prevention, and regenerative medicine. It also discusses ethical considerations and future directions for CRISPR technology in healthcare

Citation: Raiane SL (2024) CRISPR Technology in Biotechnology: Editing theFuture of Healthcare. J Biotechnol Biomater, 14: 398.

Copyright: © 2024 Raiane SL. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top